Last updated: December 19, 2023
Sponsor: Uniwersytecki Szpital Kliniczny w Opolu
Overall Status: Active - Recruiting
Phase
N/A
Condition
Kidney Disease
Renal Failure
Kidney Failure
Treatment
Measurement of Renal Resistive Index
Clinical Study ID
NCT06174610
RICRRT_USK
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All ICU patients undergoing CRRT due to AKI
Exclusion
Exclusion Criteria:
- age <18 years
- pregnancy
- history of chronic kidney disease in stage 4 or 5
- post-kidney transplant status
- mechanical circulatory support
- occurrence of one or more conditions preventing reliable RRI measurement in bothkidneys:
- challenging technical conditions of ultrasound examination, hindering propervisualization of the kidney
- post-kidney injury in grade III and higher, according to AAST
- advanced parenchymal kidney pathology: atrophy, hypoplasia, cirrhosis, extensiveischemia (more than 2/3 of the parenchyma),
- kidney diseases preventing parenchyma identification: advanced cancer (stageabove T1 according to TNM), certain forms of polycystic kidney disease
- inflammatory kidney diseases
- obstructive uropathy
- renal vascular pathologies: renal vein thrombosis, significant stenosis (>60%),and renal artery occlusion.
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Measurement of Renal Resistive Index
Phase:
Study Start date:
December 19, 2023
Estimated Completion Date:
December 18, 2025
Study Description
Connect with a study center
Department of Anesthesiology and Intensive Care, Uniwersytecki Szpital Kliniczny w Opolu
Opole, Opolskie 45-372
PolandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.